Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection

Direct-acting antiviral agents (DAAs) that allow for rapid clearance of hepatitis C virus (HCV) may evoke immunological changes. Some cases of rapid de novo hepatocellular carcinoma (HCC) development or early recurrence of HCC after DAA treatment have been reported. During chronic HCV infection, nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Pil Soo, Shin, Eui-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827927/
https://www.ncbi.nlm.nih.gov/pubmed/33435135
http://dx.doi.org/10.3390/jcm10020221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827927/
https://www.ncbi.nlm.nih.gov/pubmed/33435135
http://dx.doi.org/10.3390/jcm10020221

Ejemplares similares